𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection

✍ Scribed by G. P. Bodey; E. Anaissie; J. Gutterman; S. Vadhan-Raj

Publisher
Springer
Year
1994
Tongue
English
Weight
467 KB
Volume
13
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Intradermal ras peptide vaccination with
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma
✍ Marianne K. Gjertsen; Trond Buanes; Arne R. Rosseland; Arne Bakka; Ivar Gladhaug πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 263 KB

K-RAS mutations are frequently found in adenocarcinomas of the pancreas, and induction of immunity against mutant ras can therefore be of possible clinical benefit in patients with pancreatic cancer. We present data from a clinical phase I/II trial involving patients with adenocarcinoma of the pancr

Recombinant human granulocyte-macrophage
Recombinant human granulocyte-macrophage colony-stimulating factor in septic neutropenic pediatric cancer patients: Detection of circulating hematopoietic precursor cells correlates with rapid granulocyte recovery
✍ Fink, Franz-Martin ;Maurer-Dengg, Kathrin ;Fritsch, Gerhard ;Mann, Georg ;Zoubek πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 756 KB

## Abstract Cycling intensive chemotherapy currently used to treat pediatric solid tumors induces severe neutropenia. Prolonged neutropenia is a major risk factor for septic death which occurs in up to 5% of febrile or septic neutropenic episodes. We treated 18 neutropenic pediatric cancer patients